Solitary pituitary metastasis from HER2-positive breast cancer
Publication Year 2017-04, Volume 13, Issue #2, Page e181-e184
Journal Title
Asia Pac J Clin Oncol
Publication Type
Journal Article
The introduction of anti-HER2 therapy with trastuzumab has seen an increase in frequency of central nervous system metastasis as the site of first recurrence. Here, we present a rare case of a 63-year-old woman who presented with an isolated breast carcinoma pituitary metastasis 5 years following treatment for a high-risk breast cancer. This report underscores the changing nature of HER2-positive disease in the post-trastuzumab era.
WEHI Research Division(s)
Stem Cells And Cancer
PubMed ID
NHMRC Grants
Rights Notice
Refer to copyright notice on published article.

Creation Date: 2015-11-25 02:39:38
Last Modified: 2019-02-15 07:55:16
An error has occurred. This application may no longer respond until reloaded. Reload 🗙